Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

Simon N Rogers

    Research output: Contribution to journalArticle

    Abstract

    Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence
    Original languageEnglish
    Pages (from-to)147-149
    JournalJournal of Evidence-Based Dental Practice
    Volume10
    Issue number3
    DOIs
    Publication statusPublished - Mar 2010

    Fingerprint Dive into the research topics of 'Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible'. Together they form a unique fingerprint.

  • Cite this